跳至主要内容
临床试验/NCT02302027
NCT02302027Unknown不适用

Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache With or Without Abuse of Painkillers

Association pour la Recherche au Centre d'Urgence des Céphalées2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
percentage of patients accepted the normobaric oxygen treatment during withdrawal and consolidation phases

研究概览

简要总结

Chronic headache is most often associated with drug abuse and medication overuse headache (MOH) is the main complication of migraine disease results in chronic daily headache. The first phase of treatment consists of drug withdrawal .

The second phase of treatment (called consolidation) is to maintain the balance: treating headaches and reducing / stopping the drug use.

The aim of this study is

  1. verify the feasibility of a home withdrawal treatment with normobaric oxygen therapy (NOT) delivery by high flow concentrator
  2. use normobaric oxygen therapy (NOT) as a therapeutic measure to treat headache through withdrawal period.

It is a feasibility pilot study in chronic headache with or without medication-overuse. All patients receive a care for outpatient withdrawal that involves sudden stop drug abuse and used to be called "traditional management". The subsequent attacks will be treated with NOT from a high-flow concentrator

Primary endpoint. Feasibility study of treatment with NOT evaluated by the percentage of patients who accepted NOT during the withdrawal phase then to treat attacks.

Secondary endpoints. Efficacy will be assessed by the percentage of patients having no chronic headaches two months after the start of withdrawal (less than 15 days of headache per month) and no longer in drug abuse (less than 10 days per month with drug intake).

Visits V1 (first visit) Inclusion V2 at one month V3 at 3 months V4 (last vist) at 6 months

Effective : 30 patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Migrainous according to the criteria of the International Headache Society
  • Medication-overuse headaches according of the International Headache Society
  • No prophylaxis treatment or same prophylaxis treatment from more than one month
  • Signed informed consent

排除标准

  • Pregnancy
  • One or more failed withdrawal treatment
  • analgesic treatment for another reason than headache
  • Contraindication of normobaric oxygen therapy
  • Contraindication of ketoprofen (rescue therapy)

结局指标

主要结局

percentage of patients accepted the normobaric oxygen treatment during withdrawal and consolidation phases

时间窗: 6th month

次要结局

  • Patient Global Impressions of Change Scale(1st, 2d, 3rd, 4th, 5th and 6th month)
  • number of headache days per month(6th month)
  • Hospital Anxiety and Depression Scale(1st month, 2d month and 3rd month)
  • Headache Impact Test- 6(1st, 2d and 3rd month)
  • number of session of oxygen during the 6 months(6th month)
  • number of rescue medication taking on the 6 months(6th month)
  • Migraine Disability Assessment Questionnaire Scale(3rd and 6th month)

研究者

发起方
Association pour la Recherche au Centre d'Urgence des Céphalées
申办方类型
Other
责任方
Principal Investigator
主要研究者

Caroline ROOS

Medical Doctor

Association pour la Recherche au Centre d'Urgence des Céphalées

研究点 (2)

Loading locations...

相似试验

Feasibility Study of Normobaric Oxygen Delivered by... | 临床试验